Drug Approval | October 06, 2021
Lupin receives tentative approval for Brexpiprazole tablets
This product will be manufactured at Lupin’s Pithampur facility In India
This product will be manufactured at Lupin’s Pithampur facility In India
The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
The rates for over 400 procedures were revised
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
A total of 8308 stores are open across India and medicines are priced at affordable rates
The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas
The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
DentalMonitoring, the company that pioneered artificial intelligence in dental and orthodontic care, has announced the launch of the ScanBox
Subscribe To Our Newsletter & Stay Updated
